237 related articles for article (PubMed ID: 18303829)
1. Synthesis and structure-activity relationships of the first ferrocenyl-aryl-hydantoin derivatives of the nonsteroidal antiandrogen nilutamide.
Payen O; Top S; Vessières A; Brulé E; Plamont MA; McGlinchey MJ; Müller-Bunz H; Jaouen G
J Med Chem; 2008 Mar; 51(6):1791-9. PubMed ID: 18303829
[TBL] [Abstract][Full Text] [Related]
2. Effects of steroidal and non-steroidal antiandrogens on wild-type and mutant androgen receptors.
Urushibara M; Ishioka J; Hyochi N; Kihara K; Hara S; Singh P; Isaacs JT; Kageyama Y
Prostate; 2007 Jun; 67(8):799-807. PubMed ID: 17373727
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines.
Top S; Vessières A; Leclercq G; Quivy J; Tang J; Vaissermann J; Huché M; Jaouen G
Chemistry; 2003 Nov; 9(21):5223-36. PubMed ID: 14613131
[TBL] [Abstract][Full Text] [Related]
4. Computationally identified novel diphenyl- and phenylpyridine androgen receptor antagonist structures.
Söderholm AA; Viiliäinen J; Lehtovuori PT; Eskelinen H; Roell D; Baniahmad A; Nyrönen TH
J Chem Inf Model; 2008 Sep; 48(9):1882-90. PubMed ID: 18712859
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of carborane-containing androgen receptor (AR) antagonist bearing a pyridine ring.
Ohta K; Goto T; Fijii S; Suzuki T; Ohta S; Endo Y
Bioorg Med Chem; 2008 Sep; 16(17):8022-8. PubMed ID: 18707892
[TBL] [Abstract][Full Text] [Related]
6. Role of aromatic substituents on the antiproliferative effects of diphenyl ferrocenyl butene compounds.
Zekri O; Hillard EA; Top S; Vessières A; Pigeon P; Plamont MA; Huché M; Boutamine S; McGlinchey MJ; Müller-Bunz H; Jaouen G
Dalton Trans; 2009 Jun; (22):4318-26. PubMed ID: 19662309
[TBL] [Abstract][Full Text] [Related]
7. Developments in nonsteroidal antiandrogens targeting the androgen receptor.
Liu B; Su L; Geng J; Liu J; Zhao G
ChemMedChem; 2010 Oct; 5(10):1651-61. PubMed ID: 20853390
[No Abstract] [Full Text] [Related]
8. Synthesis, structure, and in vitro antitumor activity of some glycoside derivatives of ferrocenyl-chalcones and ferrocenyl-pyrazolines.
Zsoldos-Mády V; Csámpai A; Szabó R; Mészáros-Alapi E; Pásztor J; Hudecz F; Sohár P
ChemMedChem; 2006 Oct; 1(10):1119-25. PubMed ID: 16944543
[TBL] [Abstract][Full Text] [Related]
9. Chronic azacitidine treatment results in differentiating effects, sensitizes against bicalutamide in androgen-independent prostate cancer cells.
Gravina GL; Festuccia C; Millimaggi D; Dolo V; Tombolini V; de Vito M; Vicentini C; Bologna M
Prostate; 2008 May; 68(7):793-801. PubMed ID: 18324645
[TBL] [Abstract][Full Text] [Related]
10. Reactivity and antiproliferative activity of ferrocenyl-tamoxifen adducts with cyclodextrins against hormone-independent breast-cancer cell lines.
Buriez O; Heldt JM; Labbé E; Vessières A; Jaouen G; Amatore C
Chemistry; 2008; 14(27):8195-203. PubMed ID: 18668496
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and preliminary investigations into novel 1,2,3-triazole-derived androgen receptor antagonists inspired by bicalutamide.
Altimari JM; Niranjan B; Risbridger GP; Schweiker SS; Lohning AE; Henderson LC
Bioorg Med Chem Lett; 2014 Nov; 24(21):4948-53. PubMed ID: 25301770
[TBL] [Abstract][Full Text] [Related]
12. The discovery of a potent orally efficacious indole androgen receptor antagonist through in vivo screening.
Lanter JC; Fiordeliso JJ; Jiang W; Allan GF; Lai MT; Linton O; Hahn do W; Lundeen SG; Sui Z
Bioorg Med Chem Lett; 2007 Jan; 17(1):123-6. PubMed ID: 17071085
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationships of ferrocenyl tamoxifen derivatives with modified side chains.
Nguyen A; Top S; Pigeon P; Vessières A; Hillard EA; Plamont MA; Huché M; Rigamonti C; Jaouen G
Chemistry; 2009; 15(3):684-96. PubMed ID: 19053086
[TBL] [Abstract][Full Text] [Related]
14. Novel cyano- and N-isopropylamidino-substituted derivatives of benzo[b]thiophene-2-carboxanilides and benzo[b]thieno[2,3-c]quinolones: synthesis, photochemical synthesis, crystal structure determination, and antitumor evaluation. 2.
Jarak I; Kralj M; Suman L; Pavlović G; Dogan J; Piantanida I; Zinić M; Pavelić K; Karminski-Zamola G
J Med Chem; 2005 Apr; 48(7):2346-60. PubMed ID: 15801828
[TBL] [Abstract][Full Text] [Related]
15. Novel non-steroidal/non-anilide type androgen antagonists: discovery of 4-substituted pyrrole-2-carboxamides as a new scaffold for androgen receptor ligands.
Wakabayashi K; Miyachi H; Hashimoto Y; Tanatani A
Bioorg Med Chem; 2005 Apr; 13(8):2837-46. PubMed ID: 15781394
[TBL] [Abstract][Full Text] [Related]
16. Bicalutamide demonstrates biologic effectiveness in prostate cancer cell lines and tumor primary cultures irrespective of Her2/neu expression levels.
Gravina GL; Festuccia C; Millimaggi D; Tombolini V; Dolo V; Vicentini C; Bologna M
Urology; 2009 Aug; 74(2):452-7. PubMed ID: 19285710
[TBL] [Abstract][Full Text] [Related]
17. Comment on "Androgen-hypersensitive preclinical model of prostate cancer" by Kawata et al.
Foley R; Marignol L; Keane JP; Lynch TH; Hollywood D
Prostate; 2011 May; 71(6):559-60. PubMed ID: 20945499
[No Abstract] [Full Text] [Related]
18. Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activation.
Seaton A; Scullin P; Maxwell PJ; Wilson C; Pettigrew J; Gallagher R; O'Sullivan JM; Johnston PG; Waugh DJ
Carcinogenesis; 2008 Jun; 29(6):1148-56. PubMed ID: 18487223
[TBL] [Abstract][Full Text] [Related]
19. Toward development of targeted nonsteroidal antiandrogen-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-gadolinium complex for prostate cancer diagnostics.
Marom H; Miller K; Bechor-Bar Y; Tsarfaty G; Satchi-Fainaro R; Gozin M
J Med Chem; 2010 Sep; 53(17):6316-25. PubMed ID: 20715870
[TBL] [Abstract][Full Text] [Related]
20. First synthesis of separable isomeric testosterone dimers showing differential activities on prostate cancer cells.
Bastien D; Leblanc V; Asselin E; Bérubé G
Bioorg Med Chem Lett; 2010 Apr; 20(7):2078-81. PubMed ID: 20226660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
